Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

782
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
782
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

607
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
607
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

582
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
582
Stimulants01:29

Stimulants

841
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
841
Altered States of Awareness01:06

Altered States of Awareness

1.0K
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.0K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

672
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
672

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations.

Vaccines·2026
Same author

An Exploration of Heart Rate Response and Blood Tetrahydrocannabinol (THC) Levels to Commercially Available Cannabis Edibles by Dose.

Research square·2026
Same author

Cumulative experiences of racism and mental health outcomes in Colorado minority adolescents.

Frontiers in public health·2026
Same author

Making highways and workplaces safer: An interpretable machine learning approach to predicting recent cannabis use and impairment.

Journal of safety research·2026
Same author

Elevating Early-Career Voices in Addiction Science.

Substance use & addiction journal·2026
Same author

Health Behavior Changes in a Lifestyle Medicine Program: A Convergent Mixed Methods Study.

Behavior modification·2026

Related Experiment Video

Updated: Jan 16, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.8K

Enhancing Methods for Research on Cannabis: A Workshop Report.

Jonathan M Samet1, Jessica Barrington-Trimis2, Lisa Bero3

  • 1Colorado School of Public Health, 13001 E. 17th Place, Aurora, CO, 80045, USA. Jon.Samet@cuanschutz.edu.

Journal of Cannabis Research
|September 30, 2025
PubMed
Summary
This summary is machine-generated.

Improved cannabis research methods are urgently needed due to market changes and high-concentration products. This workshop proposed enhanced epidemiological, clinical, policy, and surveillance research strategies for better decision-making.

Keywords:
Clinical researchDelta-9-tetrahydrocannabinolDoseEpidemiological researchExposureHigh-concentration cannabisPolicyPublic healthSurveillance

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

657
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

803

Related Experiment Videos

Last Updated: Jan 16, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.8K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

657
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

803

Area of Science:

  • Public Health
  • Cannabis Science
  • Policy Research

Background:

  • State-level legalization of cannabis has spurred market growth and product diversification, particularly with high-delta-9-tetrahydrocannabinol concentrations.
  • Limited research and methodological constraints hinder evidence-based policy formulation for emerging cannabis products.

Purpose of the Study:

  • To address research limitations by convening a multidisciplinary workshop focused on advancing cannabis research methods.
  • To generate recommendations for epidemiological, clinical, surveillance, and policy research areas to inform decision-making.

Main Methods:

  • A multidisciplinary workshop was convened by the Colorado School of Public Health.
  • Participants focused on four key areas: epidemiology, clinical research, surveillance, and policy.
  • Emphasis was placed on improving the assessment of cannabis product use.

Main Results:

  • Recommendations for standardized exposure assessment measures in epidemiology, including validation and periodic updates.
  • Suggestions for clinical research include standardized dosing, data collection, and biomarker identification.
  • Policy research recommendations target state regulators and policymakers, while surveillance proposals focus on monitoring high-concentration cannabis use and adverse outcomes.

Conclusions:

  • Enhanced research methodologies are critical to improve the informativeness of cannabis research.
  • Urgent improvements are needed to keep pace with the rapidly evolving cannabis marketplace and product landscape.